PER 4.65% 9.0¢ percheron therapeutics limited

Ionis gains approval on Tofersen in Europe overnight. Very good...

  1. 304 Posts.
    lightbulb Created with Sketch. 854
    Ionis gains approval on Tofersen in Europe overnight. Very good news as this is also a second-generation antisense oligonucleotide (as ATL1102). This one is also for a rare disease ALS

    Tofersen is all about mediating mRNA degradation to prevent SOD1 protein synthesis and reduce levels of SOD1 protein.

    A nice precedent for ATL1102.


    https://www.prnewswire.com/news-releases/ionis-announces-european-medicines-agency-accepts-marketing-authorization-application-of-tofersen-to-treat-rare-genetic-form-of-als-301694129.html
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
9.0¢
Change
0.004(4.65%)
Mkt cap ! $79.33M
Open High Low Value Volume
8.6¢ 9.1¢ 8.5¢ $181.6K 2.049M

Buyers (Bids)

No. Vol. Price($)
1 10344 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
9.0¢ 64275 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.